RxDoctor Payments Data

Luiza Kofler

Family · Buffalo Grove, ILNPI 1437557741

Payments from drug & device makers

$3,314in general payments, 2019–2025

Across 144 payments — averaging $23.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$443
  • Corcept Therapeutics$353
  • Novo Nordisk$336
  • Amgen$275
  • Sanofi-aventis U.S. LLC$255
  • Teva Pharmaceuticals USA, Inc.$250
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,314100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,314 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$8,163
Medicare patients
53
Services billed
105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide16$18,654
JardianceEmpagliflozin14$18,404
Atorvastatin Calcium118$856
Losartan Potassium51$440
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide18$378
Levothyroxine Sodium38$338
Metformin Hcl ErMetformin Hcl50$328
Amlodipine Besylate46$323
Gabapentin20$290
Lisinopril39$286
Rosuvastatin Calcium14$149
Metformin Hcl19$140
Hydrochlorothiazide16$114
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide11$108
Tamsulosin Hcl11$100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$231$18,65416 claims
Boehringer IngelheimJardiance$155$18,40414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.

Other family in Buffalo Grove

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →